, Primers were as follows: mouse Ifnc 5 0-CAACAGCAAGGCGAAAAAGG-3 0 and 5 0CCTGTGGGTTGTTGACCTCAA-3 0 , mouse Gzmb, the QuantiTect reverse transcription kit (QIAGEN), and the cDNA was analyzed by realtime PCR using the SYBR Premix Ex Taq (Takara)
Maturation of mouse NK cells is a 4-stage developmental program, Blood, vol.113, pp.5488-5496, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00407779
Bone marrow versus thymic pathways of natural killer cell development, Immunol Rev, vol.214, pp.35-46, 2006. ,
T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok2, SHIP-1, and Grb-2, J Exp Med, vol.203, pp.2509-2518, 2006. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00162042
Analysis of signaling events by dynamic phosphoflow cytometry, Sci Signal, vol.2, p.3, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00408711
Functional interaction of RasGAP-binding proteins Dok1 and Dok2 with the Tec protein tyrosine kinase, Oncogene, vol.23, pp.1594-1598, 2004. ,
Dok4 is a novel negative regulator of T cell activation, J Immunol, vol.182, pp.7681-7689, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00374930
Cutting edge: Dok1 and Dok2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells, J Immunol, vol.182, pp.3974-3978, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00364224
CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity, J Immunol, vol.176, pp.1517-1524, 2006. ,
Dok1 is a positive regulator of IL-4 signalling and IgE response, J Biochem, vol.142, pp.257-263, 2007. ,
In vivo developmental stages in murine natural killer cell maturation, Nat Immunol, vol.3, pp.523-528, 2002. ,
Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases, Eur J Immunol, vol.28, pp.264-276, 1998. ,
An essential regulatory role of downstream of kinase-1 in the ovalbumin-induced murine model of asthma, PLoS ONE, vol.7, p.34554, 2012. ,
The adaptor protein Crk controls activation and inhibition of natural killer cells, Immunity, vol.36, pp.600-611, 2012. ,
Prospects for the use of NK cells in immunotherapy of human cancer, Nat Rev Immunol, vol.7, pp.329-339, 2007. ,
Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver, J Virol, vol.79, pp.661-667, 2005. ,
Controlling natural killer cell responses: integration of signals for activation and inhibition, Annu Rev Immunol, vol.31, pp.227-258, 2013. ,
The roles of Dok family adapters in immunoreceptor signaling, Immunol Rev, vol.232, pp.273-285, 2009. ,
Differential role for CD277 as a co-regulator of the immune signal in T and NK cells, Eur J Immunol, vol.41, pp.3443-3454, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00620920
The evolutionary arms race between NK cells and viruses: who gets the short end of the stick?, Eur J Immunol, vol.43, pp.867-877, 2013. ,
Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor, Proc Natl Acad Sci, vol.108, pp.18324-18329, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00672199
p62dok negatively regulates CD2 signaling in Jurkat cells, J Immunol, vol.166, pp.4408-4415, 2001. ,
Role of Dok1 and Dok2 in leukemia suppression, J Exp Med, vol.200, pp.1689-1695, 2004. ,
Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules, J Biol Chem, vol.271, pp.1591-1598, 1996. ,
Natural killer cell education and tolerance, Cell, vol.142, pp.847-856, 2010. ,
DOI : 10.1016/j.cell.2010.08.031
URL : https://doi.org/10.1016/j.cell.2010.08.031
Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties, J Clin Invest, vol.120, pp.4532-4545, 2010. ,
DOI : 10.1172/jci43961
URL : http://www.jci.org/articles/view/43961/files/pdf
Recognition of a virus-encoded ligand by a natural killer cell activation receptor, Proc Natl Acad Sci, vol.99, pp.8826-8831, 2002. ,
DOI : 10.1073/pnas.092258599
URL : http://www.pnas.org/content/99/13/8826.full.pdf
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission, Blood, vol.120, pp.4317-4323, 2012. ,
Natural killer cell signaling pathways, Science, vol.306, pp.1517-1519, 2004. ,
DOI : 10.1126/science.1103478
URL : https://hal.archives-ouvertes.fr/hal-00080580
Targeting natural killer cells and natural killer T cells in cancer, Nat Rev Immunol, vol.12, pp.239-252, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00685473
ADAPted secretion of cytokines in NK cells, Nat Immunol, vol.14, pp.1108-1110, 2013. ,
DOI : 10.1038/ni.2737
URL : https://hal.archives-ouvertes.fr/inserm-01038082
A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation, Leukemia, vol.14, pp.922-930, 2000. ,
DOI : 10.1038/sj.leu.2401769
URL : https://www.nature.com/articles/2401769.pdf
Molecular underpinning of B-cell anergy, Immunol Rev, vol.237, pp.249-263, 2010. ,
DOI : 10.1111/j.1600-065x.2010.00936.x
URL : http://europepmc.org/articles/pmc2968701?pdf=render
Dok1 and Dok2 are negative regulators of T cell receptor signaling, Int Immunol, vol.19, pp.487-495, 2007. ,
DOI : 10.1093/intimm/dxm015
URL : https://academic.oup.com/intimm/article-pdf/19/4/487/2031436/dxm015.pdf
Immunological aspects of cancer chemotherapy, Nat Rev Immunol, vol.8, pp.59-73, 2008. ,